Tony Moly to sell its stake in AtoGen subsidiary
상태바
Tony Moly to sell its stake in AtoGen subsidiary
  • By The K Beauty Science
  • Accepted 2022.10.03 12:51
  • Comments 0
이 기사를 공유합니다

Tony Moly sold its stake of AtoGEN (CEO Kang Ji-hee), a subsidiary bio-venture company that researches and develops microbiome treatments. Tony Moly announced on the 15th that it has disposed of about 338,800 shares of AtoGen for 7 billion won to Yuhan Corporation.

Through this stake sale, Tony Moly improved its financial structure by gaining a profit margin of about 4 billion won.

※For more information on this article, please contact The K Beauty Science. We offer it for free of charge, and only for those who request it. Contact: office@thekbs.co.kr


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
Comments 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.
IMPORTANT NEWS
ISSUE PHOTO